IRB Study Number 19-995
Status Recruiting
Institutes Taussig Cancer Institute, Pediatric Institute
Description
Primary Objective
Determine and prioritize domains of quality outcomes after pediatric HSCT identified by patients and families.
Inclusion Criteria
All parents/caregivers of pediatric patients (age 17.5 years or less at time of transplant) undergoing allogeneic HSCT will be invited to participate in the study. Parents/caregivers must be 18 years of age or older at the time of the study. Only one parent/caregiver per patient will be invited to participate in the study.
Exclusion Criteria
Parents/caregivers that are non-English speaking or those who will not be participating in the patient’s care at least 50% of the time.
